The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
α-Synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells
Abstract
α-Synuclein is an abundant presynaptic protein implicated in neuronal plasticity and neurodegenerative diseases. Although the function of α-synuclein is not thoroughly elucidated, we found that α-synuclein regulates dopamine synthesis by binding to and inhibiting tyrosine hydroxylase, the rate limiting enzyme in dopamine synthesis. Understanding α-synuclein function in dopaminergic cells should add to our knowledge of this key protein, which is implicated in Parkinson's disease and other disorders. Herein, we report a mechanism by which α-synuclein diminishes tyrosine hydroxylase phosphorylation and activity in stably transfected dopaminergic cells. Short-term regulation of tyrosine hydroxylase depends on the phosphorylation of key seryl residues in the amino-terminal regulatory domain of the protein. Of these, Ser40 contributes significantly to tyrosine hydroxylase activation and dopamine synthesis. We observed that α-synuclein overexpression caused reduced Ser40 phosphorylation in MN9D cells and inducible PC12 cells. Ser40 is phosphorylated chiefly by the cyclic AMP-dependent protein kinase PKA and dephosphorylated almost exclusively by the protein phosphatase, PP2A. Therefore, we measured the impact of α-synuclein overexpression on levels and activity of PKA and PP2A in our cells. PKA was unaffected by α-synuclein. PP2A protein levels also were unchanged, however, the activity of PP2A increased in parallel with α-synuclein expression. Inhibition of PP2A dramatically increased Ser40 phosphorylation only in α-synuclein overexpressors in which α-synuclein was also found to co-immunoprecipitate with PP2A. Together the data reveal a functional interaction between α-synuclein and PP2A that leads to PP2A activation and underscores a key role for α-synuclein in protein phosphorylation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“α-synuclein in the soluble form physically interacts with TH and maintains the level of phosphorylated TH in a PP2A-dependent manner [114,115,116]”
From Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia (2020) · cites this paper as [114]
Citations
Cites
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,646 · cited 1×
“α-Synuclein (α-Syn), a protein highly enriched in presynaptic terminals (Maroteaux et al., 1988), is implicated in normal brain function (George et al., 1989) as well as disease (reviewed by Perez and Hastings, 2004).”
BackgroundCeramide activates heterotrimeric protein phosphatase 2A
Dobrowsky, R. T., Kamibayashi, C., Mumby, M. C., & Hannun, Y. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82288-8 · Cited by 666 · cited 2×
“An active PP2A enzyme consists of a heterotrimer of the structural A subunit, a catalytic C subunit, and a regulatory B subunit (Dobrowsky et al., 1993).”
BackgroundProtein serine/threonine phosphatases: structure, regulation, and functions in cell growth
Mumby, M. C., & Walter, G. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.4.673 · Cited by 661 · cited 2×
“The A and C subunits are ubiquitously expressed (Mayer et al., 1991) and form the catalytic complex (PP2A/C), which interacts with at least three different families of regulatory B subunits, as well as with certain tumor antigens (Mumby and Walter, 1993).”
BackgroundA Role for α-Synuclein in the Regulation of Dopamine Biosynthesis
Perez, R. G., Waymire, J. C., Lin, E., Liu, J. J., Guo, F., & Zigmond, M. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03090.2002 · Cited by 598 · cited 8×
“Control MN9D cells with low endogenous levels of α-Syn, included both untransfected parental MN9D cells and MN9D cells stably transfected with either pcDNA3 or GFP vector (Perez et al., 2002).”
BackgroundInfluentialSelf-citationα-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins
Ostrerova, N., Petrucelli, L., Farrer, M. J., Mehta, N., Choi, P., Hardy, J., & Wolozin, B. L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05782.1999 · Cited by 560 · cited 5×
“…protein 14-3-3 (Ostrerova et al., 1999), which binds to and regulates the activity of many cellular proteins. α-Syn interacts with and affects the activity of the enzymes phospholipase D (Ahn et al., 2002), protein kinase C and the extracellular regulated kinases (ERK) (Ostrerova et al., 1999).”
BackgroundInfluentialTyrosine hydroxylase phosphorylation: Regulation and consequences
Dunkley, P. R., Bobrovskaya, L., Graham, M. E., Von Nagy‐Felsobuki, E. I., & Dickson, P. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02797.x · Cited by 455 · cited 3×
“Since it is well-documented that Ser40 dephosphorylation occurs almost exclusively by PP2A (Berresheim and Kuhn, 1994; Dunkley et al., 2004; Haavik et al., 1989; Leal et al., 2002) our findings indicate that (1) TH Ser40 is dephosphorylated by PP2A in dopaminergic cells, and (2) the Ser40 residue on TH remains accessi…”
BackgroundJenco, J. M., Rawlingson, A., Daniels, B., & Morris, A. J. (1998) · Biochemistry · doi:10.1021/bi972776r · Cited by 431 · cited 2×
“…kinase mediating Ser40 phosphorylation and because α-Syn is so strongly implicated in enzymatic inhibition, e.g. ERK2, PLD2, TH (Iwata et al., 2001; Jenco et al., 1998; Perez et al., 2002) we first hypothesized that the reduction in TH Ser40 phosphorylation was probably occurring by α-Syn…”
BackgroundPerez, R. G., Soriano, S., Hayes, J. D., Ostaszewski, B. L., Xia, W., Selkoe, D. J., Chen, X., Stokin, G. B., & Koo, E. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.18851 · Cited by 387 · cited 1×
“Cell lysates prepared in 1% NP40 buffer containing protease inhibitors were sonicated for ∼5 seconds and particulates were eliminated by centrifugation at 15,000 g for 10 minute at 4°C as previously described (Perez et al., 1999).”
MethodSelf-citationMcCright, B., Rivers, A. M., Audlin, S., & Virshup, D. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.22081 · Cited by 382 · cited 2×
“…there is evidence that B subunits are associated with targeting the PP2A/C catalytic complexes to various intracellular sites such as microtubules (McCright et al., 1996; Sontag et al., 1995) and mitochondria (Ruvolo et al., 2002) suggesting that PP2A complexes are actively trafficked by their…”
BackgroundIchimura, T., Isobe, T., Okuyama, T., Takahashi, N., Araki, K., Kuwano, R., & Takahashi, Y. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.19.7084 · Cited by 339 · cited 4×
“It is known that 14-3-3 can activate TH (Ichimura et al., 1988) by 14-3-3 binding first to TH Ser19 then to TH Ser40 (Kleppe et al., 2001).”
BackgroundInfluentialSontag, E., Nunbhakdi‐Craig, V., Bloom, G. S., & Mumby, M. C. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.128.6.1131 · Cited by 301 · cited 2×
“…B subunits are associated with targeting the PP2A/C catalytic complexes to various intracellular sites such as microtubules (McCright et al., 1996; Sontag et al., 1995) and mitochondria (Ruvolo et al., 2002) suggesting that PP2A complexes are actively trafficked by their associated interacting…”
BackgroundJOH, T. H., Park, D. H., & Reis, D. J. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.10.4744 · Cited by 284 · cited 2×
“, 1993), it is the cAMP-dependent protein kinase PKA (Joh et al., 1978) that predominantly phosphorylates TH Ser40 in vivo (Campbell et al.”
BackgroundIdentification of four phosphorylation sites in the N-terminal region of tyrosine hydroxylase.
Campbell, D. G., Hardie, D. G., & Vulliet, P. R. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67410-1 · Cited by 243 · cited 6×
“…S ci en ce 3524 PKC (Albert et al., 1984; Vulliet et al., 1985), MSK-1 (Toska et al., 2002), MAPKAP kinases 1 and 2 (Sutherland et al., 1993), it is the cAMP-dependent protein kinase PKA (Joh et al., 1978) that predominantly phosphorylates TH Ser40 in vivo (Campbell et al., 1986; Wu et al., 1992).”
BackgroundInfluentialPhosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40.
Haycock, J. W. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38451-0 · Cited by 224 · cited 1×
“The regulation of TH activity in the short term depends on the phosphorylation of key seryl residues (Ser19, Ser31 and Ser40) in the amino-terminal regulatory domain (Campbell et al., 1986; Haycock, 1990).”
BackgroundIdentification of a New Family of Protein Phosphatase 2A Regulatory Subunits
McCright, B., & Virshup, D. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26123 · Cited by 222 · cited 2×
“The regulatory B subunits of PP2A are known to be temporally expressed during development (Csortos et al., 1996; Mayer et al., 1991; McCright and Virshup, 1995; Ruediger et al., 1991) and neuron-specific isoforms have also been identified (Mayer et al.”
BackgroundAlbert, K. A., Helmer-Matyjek, E., Nairn, A. C., Müller, T. H., Haycock, J. W., Greene, L. A., Goldstein, M., & Greengard, P. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7713 · Cited by 219 · cited 2×
“Jo ur na l o f C el l S ci en ce 3524 PKC (Albert et al., 1984; Vulliet et al., 1985), MSK-1 (Toska et al., 2002), MAPKAP kinases 1 and 2 (Sutherland et al., 1993), it is the cAMP-dependent protein kinase PKA (Joh et al., 1978) that predominantly phosphorylates TH Ser40 in vivo (Campbell et al.,…”
BackgroundTrojanowski, J. Q., & Lee, V. M. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.15.8529836 · Cited by 216 · cited 2×
“…PP2A may affect PP2A conformation or trafficking and subsequently contribute to its activation. α-Syn oxidative modification or aggregation occurs in neurodegenerative diseases such as Alzheimer’s disease, a condition in which PP2A is also implicated (Trojanowski and Lee, 1995; Zhao et al., 2003).”
BackgroundIdentities of Sequestered Proteins in Aggregates from Cells with Induced Polyglutamine Expression
Suhr, S. T., Senut, M., Whitelegge, J. P., Faull, K. F., Cuizon, D. B., & Gage, F. H. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.2.283 · Cited by 216
Mayer, R. E., Hendrix, P., Cron, P. D., Matthies, R., Stone, S. R., Goris, J., Merlevede, W. J., Hofsteenge, J., & Hemmings, B. A. (1991) · Biochemistry · doi:10.1021/bi00229a001 · Cited by 211 · cited 4×
“, 1991) and neuron-specific isoforms have also been identified (Mayer et al., 1991).”
BackgroundInfluentialImmortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion
Choi, H. K., Won, L., Kontur, P. J., Hammond, D. N., Fox, A. P., Wainer, B. H., Hoffmann, P. C., & Heller, A. (1991) · Brain Research · doi:10.1016/0006-8993(91)90661-e · Cited by 210 · cited 2×
“The MN9D dopaminergic cells express abundant TH (Choi et al., 1991) and synthesize DA (Choi et al.”
BackgroundSutherland, C. D., ALTERIO, J., CAMPBELL, D. G., Bourdellès, B. L., Mallet, J. J., Haavik, J., & Cohen, P. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18297.x · Cited by 177 · cited 2×
“Jo ur na l o f C el l S ci en ce 3524 PKC (Albert et al., 1984; Vulliet et al., 1985), MSK-1 (Toska et al., 2002), MAPKAP kinases 1 and 2 (Sutherland et al., 1993), it is the cAMP-dependent protein kinase PKA (Joh et al., 1978) that predominantly phosphorylates TH Ser40 in vivo (Campbell et al.,…”
BackgroundHigh Complexity in the Expression of the B′ Subunit of Protein Phosphatase 2A0
Csoŕtos, C., Zołnierowicz, S., Bakó, É., Durbin, S. D., & DePaoli-Roach, A. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2578 · Cited by 163 · cited 4×
“The substrate specificity of PP2A appears to be determined by the regulatory B subunits (Cegielska et al., 1994; Csortos et al., 1996) and there is evidence that B subunits are associated with targeting the PP2A/C catalytic complexes to various intracellular sites such as microtubules (McCright et…”
BackgroundInfluentialRuvolo, P. P., Clark, W., Mumby, M. C., Gao, F., & May, W. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201830200 · Cited by 153 · cited 2×
“, 1995) and mitochondria (Ruvolo et al., 2002) suggesting that PP2A complexes are actively trafficked by their associated interacting proteins, one of which may be α-Syn.”
Backgroundα-Synuclein Affects the MAPK Pathway and Accelerates Cell Death
Iwata, A., Maruyama, M., Kanazawa, I., & Nukina, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103736200 · Cited by 139 · cited 3×
“ERK2, PLD2, TH (Iwata et al., 2001; Jenco et al., 1998; Perez et al., 2002) we first hypothesized that the reduction in TH Ser40 phosphorylation was probably occurring by α-Syn inhibition of PKA.”
BackgroundAhn, B., Rhim, H., Kim, S. Y., Sung, Y., Lee, M., Choi, J., Wolozin, B. L., Chang, J., Lee, Y. H., Kwon, T. K., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110414200 · Cited by 136 · cited 1×
“…protein 14-3-3 (Ostrerova et al., 1999), which binds to and regulates the activity of many cellular proteins. α-Syn interacts with and affects the activity of the enzymes phospholipase D (Ahn et al., 2002), protein kinase C and the extracellular regulated kinases (ERK) (Ostrerova et al., 1999).”
BackgroundCould a loss of α‐synuclein function put dopaminergic neurons at risk?
Perez, R. G., & Hastings, T. G. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02423.x · Cited by 133 · cited 1×
“α-Synuclein (α-Syn), a protein highly enriched in presynaptic terminals (Maroteaux et al., 1988), is implicated in normal brain function (George et al., 1989) as well as disease (reviewed by Perez and Hastings, 2004).”
BackgroundSelf-citationCegielska, A., Shaffer, S. A., Derua, R., Goris, J., & Virshup, D. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4616 · Cited by 108
Haavik, J., Schelling, D. L., Campbell, D. G., Andersson, K. K., Flatmark, T., & Cohen, P. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81424-3 · Cited by 103 · cited 10×
“, 2002), which reduces TH activity both in dopaminergic cells (Haavik et al., 1989) and in rat striatum (Bevilaqua et al.”
BackgroundMethodInfluentialCharacterization of the Active Site Iron in Tyrosine Hydroxylase
Ramsey, A., Hillas, P., & Fitzpatrick, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24395 · Cited by 102 · cited 1×
“Of these, phosphorylated Ser40 is a major contributor to DA synthesis in vivo (Ramsey et al., 1996).”
BackgroundSuhr, S. T., Gil, E. B., Senut, M., & Gage, F. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7999 · Cited by 98 · cited 1×
“These constructs form the basis of the ‘bomb system’ for inducible transgene expression (Suhr et al., 1998; Suhr et al., 2001) and were generously provided by Fred Gage and Steve Suhr at the Salk Institute (La Jolla, CA, USA).”
MethodChoi, H. K., Won, L., Roback, J. D., Wainer, B. H., & Heller, A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.8943 · Cited by 96 · cited 1×
“The MN9D dopaminergic cells express abundant TH (Choi et al., 1991) and synthesize DA (Choi et al., 1992).”
BackgroundVulliet, P. R., Woodgett, J. R., Ferrari, S. M., & Hardie, D. G. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80328-8 · Cited by 94 · cited 1×
“Jo ur na l o f C el l S ci en ce 3524 PKC (Albert et al., 1984; Vulliet et al., 1985), MSK-1 (Toska et al., 2002), MAPKAP kinases 1 and 2 (Sutherland et al., 1993), it is the cAMP-dependent protein kinase PKA (Joh et al., 1978) that predominantly phosphorylates TH Ser40 in vivo (Campbell et al.,…”
BackgroundConstant Expression and Activity of Protein Phosphatase 2A in Synchronized Cells
Ruediger, R., Hood, J., Mumby, M. C., & Walter, G. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.8.4282-4285.1991 · Cited by 89 · cited 2×
“The regulatory B subunits of PP2A are known to be temporally expressed during development (Csortos et al., 1996; Mayer et al., 1991; McCright and Virshup, 1995; Ruediger et al., 1991) and neuron-specific isoforms have also been identified (Mayer et al.”
BackgroundSynuclein‐1 is selectively up‐regulated in response to nerve growth factor treatment in PC12 cells
Stefanis, L., Kholodilov, N. G., Rideout, H. J., Burke, R. E., & Greene, L. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00114.x · Cited by 89 · cited 2×
“Generation of stably transfected inducible PC12 cell lines α-Syn was cloned into pcDNA3 as previously described (Stefanis et al., 2001) followed by subcloning into the SKSP shuttle cloning vector using HindIII-XhoI.”
MethodSelf-citationUgarte, S. D., Lin, E., Klann, E., Zigmond, M. J., & Perez, R. G. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10632 · Cited by 89 · cited 1×
“Low-passage number MN9D cells were grown as previously described (Ugarte et al., 2003).”
MethodSelf-citationBegum, N., & Ragolia, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31166 · Cited by 86 · cited 2×
“2). α-Syn increases PP2A activity and binds to the PP2A catalytic domain We measured PP2A activity from the MN9D and induced PC12 cells using a well-established immunoprecipitation and phosphatase activity protocol (Begum and Ragolia, 1996).”
MethodPhosphorylation of Tyrosine Hydroxylase by Cyclic GMP‐Dependent Protein Kinase
Roskoski, R. J., Vulliet, P. R., & Glass, D. B. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb05593.x · Cited by 82 · cited 2×
“Although multiple kinases can phosphorylate TH on Ser40 in vitro, including cyclic GMP-dependent protein kinase (Rodriguez-Pascual et al., 1999; Roskoski et al., 1987), CamKII (Campbell et al., 1986; Yamauchi and Fujisawa, 1981), 3523 α-Synuclein is an abundant presynaptic protein implicated in…”
BackgroundBevilaqua, L. R., Graham, M. E., Dunkley, P. R., von Nagy‐Felsobuki, E. I., & Dickson, P. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105280200 · Cited by 80 · cited 1×
“There is additional evidence that the binding of 14-3-3 to TH phosphorylated on Ser19 and Ser40 stabilizes its conformation and enhances TH activity (Bevilaqua et al., 2001).”
BackgroundKleppe, R., Toska, K., & Haavik, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00318.x · Cited by 71 · cited 2×
“It is known that 14-3-3 can activate TH (Ichimura et al., 1988) by 14-3-3 binding first to TH Ser19 then to TH Ser40 (Kleppe et al., 2001).”
BackgroundGarcia, L., Garcia, F., Llorens, F., Unzeta, M., Itarte, E., & Gómez, N. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02950-2 · Cited by 48 · cited 2×
“Furthermore, we treated cells with low to high dose okadaic acid (5 nM-1 μM) dissolved in DMSO (0.13 μM) (Garcia et al., 2002; Haavik et al., 1989) for 1 hour to assess the impact on PP2A inhibition in the presence of α-Syn overexpression and saw a similar effect.”
BackgroundMethodInfluentialGeorge, R. J., Haycock, J. W., Johnston, J. P., Craviso, G. L., & Waymire, J. C. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb10928.x · Cited by 39 · cited 2×
“α-Synuclein (α-Syn), a protein highly enriched in presynaptic terminals (Maroteaux et al., 1988), is implicated in normal brain function (George et al., 1989) as well as disease (reviewed by Perez and Hastings, 2004).”
BackgroundSite-directed mutagenesis of tyrosine hydroxylase. Role of serine 40 in catalysis.
Wu, J., Filer, D., Friedhoff, A. J., & Goldstein, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35673-4 · Cited by 38 · cited 2×
“, 1978) that predominantly phosphorylates TH Ser40 in vivo (Campbell et al., 1986; Wu et al., 1992).”
BackgroundZhao, W., Feng, C., & Alkon, D. L. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00124-4 · Cited by 36 · cited 2×
“…PP2A may affect PP2A conformation or trafficking and subsequently contribute to its activation. α-Syn oxidative modification or aggregation occurs in neurodegenerative diseases such as Alzheimer’s disease, a condition in which PP2A is also implicated (Trojanowski and Lee, 1995; Zhao et al., 2003).”
BackgroundYamauchi, T., & Fujisawa, H. (1981) · FEBS Letters · doi:10.1016/0014-5793(81)80769-7 · Cited by 36 · cited 1×
“…Ser40 in vitro, including cyclic GMP-dependent protein kinase (Rodriguez-Pascual et al., 1999; Roskoski et al., 1987), CamKII (Campbell et al., 1986; Yamauchi and Fujisawa, 1981), 3523 α-Synuclein is an abundant presynaptic protein implicated in neuronal plasticity and neurodegenerative diseases.”
BackgroundTyrosine Hydroxylase Dephosphorylation by Protein Phosphatase 2A in Bovine Adrenal Chromaffin Cells
Leal, R. B., Sim, A. T. R., Gonçalves, C. A., & Dunkley, P. R. (2002) · Neurochemical Research · doi:10.1023/a:1014880403970 · Cited by 33 · cited 7×
“It is well documented that dephosphorylation of TH Ser40 occurs almost exclusively by the phosphatase PP2A (Berresheim and Kuhn, 1994; Haavik et al., 1989; Leal et al., 2002), which reduces TH activity both in dopaminergic cells (Haavik et al.”
BackgroundInfluentialAddison, J. A. (1996) · Ecotoxicology and Environmental Safety · doi:10.1006/eesa.1996.0006 · Cited by 31 · cited 1×
“Tebufenozide, which is a molt-inducing insecticide that mimics the action of ecdysone (Addison, 1996), was used for induction of α-Syn expression.”
MethodBevilaqua, L. R., Cammarota, M., Dickson, P. W., Sim, A. T. R., & Dunkley, P. R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01792.x · Cited by 30 · cited 1×
“It is well documented that dephosphorylation of TH Ser40 occurs almost exclusively by the phosphatase PP2A (Berresheim and Kuhn, 1994; Haavik et al., 1989; Leal et al., 2002), which reduces TH activity both in dopaminergic cells (Haavik et al., 1989) and in rat striatum (Bevilaqua et al., 2003).”
BackgroundRodríguez‐Pascual, F., Ferrero, R., Miras‐Portugal, M. T., & Torres, M. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1199 · Cited by 28 · cited 2×
“Although multiple kinases can phosphorylate TH on Ser40 in vitro, including cyclic GMP-dependent protein kinase (Rodriguez-Pascual et al., 1999; Roskoski et al., 1987), CamKII (Campbell et al., 1986; Yamauchi and Fujisawa, 1981), 3523 α-Synuclein is an abundant presynaptic protein implicated in…”
BackgroundBerresheim, U., & Kuhn, D. M. (1994) · Brain Research · doi:10.1016/0006-8993(94)91244-0 · Cited by 25 · cited 5×
“Since it is well-documented that Ser40 dephosphorylation occurs almost exclusively by PP2A (Berresheim and Kuhn, 1994; Dunkley et al., 2004; Haavik et al., 1989; Leal et al., 2002) our findings indicate that (1) TH Ser40 is dephosphorylated by PP2A in dopaminergic cells, and (2) the Ser40 residue…”
BackgroundInfluentialPhosphorylation of Tyrosine Hydroxylase in Isolated Mice Adrenal Glands
Toska, K., Kleppe, R., Cohen, P., & Haavik, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04435.x · Cited by 16 · cited 3×
“Jo ur na l o f C el l S ci en ce 3524 PKC (Albert et al., 1984; Vulliet et al., 1985), MSK-1 (Toska et al., 2002), MAPKAP kinases 1 and 2 (Sutherland et al., 1993), it is the cAMP-dependent protein kinase PKA (Joh et al., 1978) that predominantly phosphorylates TH Ser40 in vivo (Campbell et al.,…”
BackgroundDevelopmental Regulation of Protein Phosphatase Types 1 and 2A in Post-Hatch Chicken Brain
Sim, A. T. R., Collins, E., Mudge, L.-M., & Rostas, J. A. P. (1998) · Neurochemical Research · doi:10.1023/a:1022422332404 · Cited by 15 · cited 1×
“Membrane bound PP2A in brain is reportedly less active (Sim et al., 1998), thus the interaction of PP2A with α-Syn within the cytosol may serve to stimulate PP2A activity.”
Background
Cited by
Sorted by citations
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446
“a-Synuclein is quite promiscuous in its binding properties, and may bind various proteins in neuronal cells, including components of dopamine metabolism, such as tyrosine hydroxylase (TH) and the dopamine transporter (DAT), modulating their function (Ostrerova et al. 1999; Perez et al. 2002; Wersinger and Sidhu 2003;…”
BackgroundSelf-citationα-Synuclein misfolding and Parkinson's disease
Breydo, L., Wu, J., & Uversky, V. N. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.002 · Cited by 683
“TBP-1 [332,333], phospholipase D [334], protein phosphatase 2A [335], DAT [336], mitochondrial complex IV enzyme cytochrome oxidase”
BackgroundCell Biology and Pathophysiology of α-SynucleinPreprint
Burré, J., Sharma, M., & Südhof, T. C. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024091 · Cited by 626
The Synaptic Function of α-Synuclein
Burré, J. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150642 · Cited by 610
“-Synuclein inhibits dopamine synthesis by inhibiting the expression and activity of tyrosine hydroxylase [154, 168–170, 204], likely via reducing the phosphorylation state of tyrosine hydroxylase and stabilizing dephosphorylated inactive tyrosine hydroxylase [168, 205–207].”
BackgroundLarsen, K. E., Schmitz, Y., Troyer, M. D., Mosharov, E. V., Dietrich, P., Quazi, A. Z., Savalle, M., Nemani, V. M., Chaudhry, F. A., Edwards, R. H., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3821-06.2006 · Cited by 424
“…on effects of the protein on catecholamine synthesis, uptake, and vesicular accumulation (Lee et al., 2001; Lotharius et al., 2002; Perez et al., 2002; Wersinger et al., 2003; Peng et al., 2005), is that amount of transmitter released per vesicle fusion event (quantal size) might be decreased.”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Peng, X. M., Tehranian, R., Dietrich, P., Stefanis, L., & Perez, R. G.
- Affiliations
- University of Pittsburgh (US)
- Columbia University (US)
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 2005-08-01
- Volume
- 118
- Issue
- 15
- Pages
- 3523-3530
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2077584190
- Cited by
- 249
- References
- 52
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 13 · 2023: 11 · 2022: 12 · 2021: 16 · 2020: 18 · 2019: 18 · 2018: 13 · 2017: 16 · 2016: 8 · 2015: 7 · 2014: 13 · 2013: 13 · 2012: 21
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cell Science (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS42094, R01NS042094)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- alpha-synuclein, protein phosphatase 2A, tyrosine hydroxylase, tyrosine hydroxylase phosphorylation, dopamine synthesis, dopaminergic neurons, protein kinase A, protein dephosphorylation, Parkinson's disease, protein-protein interaction
- MeSH terms
- Animals, Cell Line, Dopamine, Gene Expression Regulation, Mice, Inbred C57BL, Phosphoprotein Phosphatases, Phosphorylation, Serine, Tyrosine 3-Monooxygenase, PC12 Cells, Okadaic Acid, Mice, Rats, Protein Phosphatase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review